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In Brief
Lymphocyte infiltration of non-lymphoid
tissues, including adipose and vascular
tissues, is a prominent feature of chronic
inflammation in diet obesity. Mauro et al.
find that the saturated fatty-acid
palmitate activates a PI3K p110d-Akt
pathway leading to CD4+ T cell
differentiation into effector memory-like
T cells upon priming in obese mice and
humans.
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Low-grade systemic inflammation associated to
obesity leads to cardiovascular complications,
caused partly by infiltration of adipose and vascular
tissue by effector T cells. The signals leading to
T cell differentiation and tissue infiltration during
obesity are poorly understood. We tested whether
saturated fatty acid-induced metabolic stress affects
differentiation and traffickingpatterns of CD4+ T cells.
Memory CD4+ T cells primed in high-fat diet-fed do-
nors preferentially migrated to non-lymphoid, inflam-
matory sites, independent of the metabolic status of
the hosts. Thiswasdue to biasedCD4+ T cell differen-
tiation into CD44hi-CCR7lo-CD62Llo-CXCR3+-LFA1+
effector memory-like T cells upon priming in high-
fat diet-fed animals. Similar phenotype was observed
inobesesubjects inacohort of free-livingpeople.This
developmental bias was independent of any cross-
talk between CD4+ T cells and dendritic cells and
was mediated via direct exposure of CD4+ T cells to
palmitate, leading to increased activation of a PI3K
p110d-Akt-dependent pathway upon priming.
INTRODUCTION
Obesity is a major and ever growing burden on public health
worldwide. Individualswithobesity areat increased riskof several
health conditions including type 2 diabetes, dyslipidaemia, liver
steatosis, hypertension, cardiovascular disease, osteoarthritis,
as well as various forms of cancer (Faulds and Dahlman-Wright,
2012;MauroandMarelli-Berg, 2012;Norata et al., 2015). A strong
link between obesity and the establishment of chronic systemicCell Metabolism 25, 593–609,
This is an open access article undinflammation has recently emerged (Bjørndal et al., 2011) and is
often related to increased expression of adipokines (i.e., leptin,
chemerin, and resistin), myokines, and pro-inflammatory media-
tors (i.e., tumor necrosis factor [TNF]-a, interleukin [IL]-1, and IL-
6), and decreased expression of the anti-inflammatory cytokine,
adiponectin (Norata et al., 2015). In obesity, activated immune
cells (including T cells, macrophages, and dendritic cells [DC])
infiltrate adipose tissue, promoting in turn the production of
pro-inflammatory cytokines, such as TNF-a, IL-6, resistin, and
monocyte chemotactic protein-1 (MCP-1/CCL2) (Mathis and
Shoelson, 2011; Norata et al., 2015). This process is thought to
underlay the activation of both the innate and adaptive arms of
the immune system, which results in the chronic inflammatory
response observed in obese subjects (Larbi et al., 2008; Shaw
et al., 2010). While T cells, B cells, macrophages, neutrophils,
andmast cells are increased in number in the visceral adipose tis-
sue (AT) of obese individuals, specific subsets of T cells (helper
T cell type [Th2], regulatory T cells, and invariant natural killer T
[iNKT] cells), as well as eosinophils are reduced (Cildir et al.,
2013). Obesity-related inflammation, caused by excessive and
inappropriate activation of the immune system, is pivotal to dis-
ease progression and the development of complications, such
asatherosclerosis and type2diabetes (Norata et al., 2015). T lym-
phocytes play amajor role in the development of these inflamma-
tory processes both via direct cytotoxic activities and secretion of
cytokines that influence the severity and outcome of the inflam-
matory reaction (Hamann et al., 2000). Based on the observation
that T cells in the adipose tissue display specific T cell receptor
(TCR) rearrangements, it has been proposed that obesity
might be associated with an autoimmune response (Gerriets
and Rathmell, 2012).
The mechanisms of enhanced T cell activation and tissue infil-
tration during obesity, however, remain elusive.
Altered antigen presentation by DC has been proposed to un-
derlie the activation of adaptive immunity observed in dyslipi-
daemia. Although AT-derived DC in obesity display an immatureMarch 7, 2017 ª 2017 The Authors. Published by Elsevier Inc. 593
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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phenotype with lower expression of activation markers, such
as CD40, CD80, and CD86 (Chen et al., 2014), they promote
the differentiation of pro-inflammatory interferon (IFN)g+ CD4+
T cells (Chen et al., 2014).
A recent report has implicated dietary long- and medium-
chain fatty acids (FA) in T cell differentiation toward Th1 and
Th17 subsets in autoimmune responses of the CNS (Haghikia
et al., 2015); however, whether FA can directly affect T cell acti-
vation and differentiation toward specific cell subsets during
metabolic overload remains to be established.
In this study, we investigated the phenotypic, functional, and
migratory features of memory CD4+ T cells in experimental
models of saturated FA-induced metabolic stress, as well as in
human CD4+ T cells obtained from lean, overweight, and obese
individuals in a large cohort of free-living people (Progressione
della Lesione Intimale Carotidea [PLIC] study: n = 2,606). Mech-
anistic studies show that direct exposure of CD4+ T cells to satu-
rated FA; i.e., palmitate, which is enriched in high-fat diet (HFD),
induces CD4+ T cells to acquire a specific CD44hi-CCR7lo-
CD62Llo-CXCR3+-LFA1+ pro-inflammatory functional pheno-
type via enhanced engagement of a PI3K p110d-Akt-dependent
pathway upon priming, but independent of the modality of anti-
gen presentation by DC.
RESULTS
Priming following HFD Induces Differentiation of a CD4+
T Cell Population that Readily Migrates to Inflamed,
Non-lymphoid Tissues Independent of the Metabolic
Status of the Host
Given that lymphocyte infiltration of non-lymphoid tissues is a
prominent feature of chronic inflammation, we first assessed
whether HFD-induced metabolic stress directly promotes the
generation of T cell populations with specific migratory features.
To this aim, memory CD4+ T cells were generated in Rag2-defi-
cient TCR transgenic Marilyn female mice, which harbor mono-
clonal CD4+ T cells specific for the male antigen H-Y (Lantz
et al., 2000), by intraperitoneal (i.p.) injection of male splenocytes
(Robertson et al., 2007). CD4+ T cells were then isolated from the
lymph nodes of donors fed 8-week chow (CD) or HFD and adop-
tively transferred in HFD- or CD-fed (i.e. fed chow or high-fat diet
for 8weeks, respectively) C57BL/6male recipients that had been
i.p. injected with zymosan and IFNg 48 hr earlier to induce local-
ized inflammation (Figures S1A–S1C) (Fu et al., 2014). In vivo-
primed CD4+ T cells isolated from HFD donors exited from the
blood circulation of CD recipients with a kinetic 24 hr faster
than their CD counterpart (Figure 1A). CD4+ T cells that wereFigure 1. Priming followingHFD Induces Differentiation of a CD4+ TCel
Independent of the Metabolic Status of the Host
In vivo-primed CD4+ T cells isolated from pooled lymph nodes of HFD or CDMaril
in different tissue compartments (as described) of HFD or CD C57BL/6 male re
previously i.p. injected with zymosan (1 mg/mouse) and IFNg (600 U/mouse).
(A) Dot plots and quantification of donor cells in the blood circulation of CD recip
(B–D) Dot plots and quantification of the localization of donor cells, fluorescently
lymph nodes (C), and spleen (D) of HFD or CD recipient mice.
(E) Survival curve of C57BL/6 male skin grafts on HFD or CD Marilyn female reci
(A–D) n = 4–6 independent recipients.
(E) n = 7 HFD, n = 9 CD independent recipients. (A–D) The values denote mean ±primed in HFD donors also trafficked preferentially to the
non-lymphoid, inflamed sites (peritoneal cavity) of both HFD
and CD recipients (Figure 1B). In contrast, primed CD4+ T cells
from CD donors preferentially localized to the mesenteric lymph
nodes of both CD and HFD recipients (Figure 1C). No difference
in CD4+ T cell localization to the spleen was observed when
comparing equal numbers of adoptively transferred CD and
HFD donors (Figure 1D). These results indicate that memory
T cell populations induced in CD- or HFD-fed animals are char-
acterized by different trafficking patterns.
To establish the pathophysiological relevance of these differ-
ential trafficking patterns, we performed HY-mismatched skin
grafts, whereby male skin was implanted on the upper right
back of CD- or HFD-fed Marilyn female recipients. We found
that rejection of HY-mismatched skin was significantly acceler-
ated in HFD as compared to CD female recipients (Figure 1E)
(Molinero et al., 2016). Activation of CD4+ T cells and their local-
ization to the graft are known to be instrumental to rejection in
this system (Chen et al., 2003). Indeed, we observed that HY-
mismatched skin graft rejection was completely abrogated in
Rag2KO mice (that are deficient for mature T and B cells) inde-
pendent of the diet they received (Figure S1D). Reconstitution
of HFD Rag2KO mice with CD4+ T cells isolated from Marilyn
mice resulted in a rapid rejection of the transplanted male-
derived skin (Figure S1D), showing the crucial role these cells
play in such system. These findings support the conclusion
that biased differentiation of CD4+ T cells toward a pro-inflam-
matory effector memory phenotype takes place during HFD-
induced metabolic stress.
HFD-Induced Metabolic Stress Promotes the
Differentiation of Primed CD4+ T Cells to a
CXCR3+-LFA1+ Effector Memory-like Phenotype in Mice
Based on the distinct homing preferences of memory T cells
generated in HFD- or CD-fed animals and the stronger immune
response elicited in HFDanimals, we askedwhether a biased dif-
ferentiation of activated CD4+ T cells toward a pro-inflammatory
phenotype—and associated homing receptors—takes place
upon priming following HFD-induced metabolic stress.
Using the same immunization procedure as that used for the
experiments presented in Figures 1A–1D, we found that HFD-
fed hosts displayed an increase in the size of the CD44hi-
CCR7lo-CD62Llo-CXCR3+-LFA1+ effector memory-like CD4+
T cell population and no difference in the CD44hi-CCR7hi-
CD62Lhi central memory CD4+ T cells as compared to CD4+
T cells primed in CD-fed mice (Figures 2A–2D and S2A–S2D).
In contrast, the size of naive T cells was reduced in HFD (Figuresl Population that Readily Migrates to Inflamed, Non-lymphoid Tissues
yn female donor mice, fluorescently labeled with CFSE or PKH26, respectively,
cipient mice 48 hr post-i.v. injection of donor cells. The male recipients were
ient mice; 2 hr, 24 hr, and 48 hr post-i.v. injection of donor cells.
labeled with CFSE (HFD) or PKH26 (CD) in the peritoneal cavity (B), mesenteric
pient mice up to 28 days post-transplantation.
SEM. *p < 0.05; **p < 0.01; and ***p < 0.001. Mantel-Cox test, *p < 0.05.
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2A, 2B, S2A, and S2B). These data suggest a preferential CD4+
T cell differentiation toward an effector memory phenotype un-
der HFD regimen in concomitance with a reciprocal reduction
of the naive cell population without affecting the size of the cen-
tral memory pool. No difference was observed in the expression
of the activation markers CD25 and CD44 (Figures 2E, 2F, S2E,
and S2F) by memory CD4+ T cells activated in CD or HFD hosts,
indicative of similar priming efficiency in either metabolic back-
ground. In agreement with the observed phenotypes, a signifi-
cantly larger fraction of in vivo-primed CD4+ T cells isolated
from the lymph nodes of HFD mice migrated in response to the
pro-inflammatory chemokine CXCL10 (a CXCR3 ligand) in
ex vivo chemotaxis assays, while most in vivo-primed CD4+
T cells isolated from the lymph nodes of CD mice migrated to
the homeostatic lymphoid tissue chemokines CCL19 and
CCL21 (ligands of CCR7) (Figure 2G). To investigate the cellular
sources of CXCL10 in vivo, mice received an i.p. injection of
IFNg. At 48 hr later, intracellular staining of CXCL10 in a number
of immune cell populations retrieved from the peritoneal cavity
was performed. We chose this system because of its relevance
to the peritoneal recruitment system shown in Figures 1A–1D.
Data indicate that resident (peritoneal) and to a less extent infil-
trating (monocyte-derived) macrophages are main sources of
CXCL10 in this model (Figures S2G and S2H). Furthermore, we
observed an increase in the IFNg+ and IL4+ populations upon
priming following HFD (Figures 2H and 2I).
Our findings are in line with previous work showing that
increased expression of CXCR3 in inflammatory conditions,
such as obesity and atherosclerosis, drives accumulation of in-
flammatory T cells in fat sites. Indeed, CXCR3- or CXCL10-defi-
cient mice are protected from obesity- and atherosclerosis-
induced inflammation in association with reduced accumulation
of effector T cells and macrophages in AT and atherosclerotic
plaques (Gupta et al., 1997; Rocha et al., 2014; Veillard
et al., 2005).
Obesity Is Associated with Increased Numbers of
Circulating CXCR3+ Effector Memory T Cells in Humans
A cohort of 1,172 subjects was selected by probability sampling
from a large survey of free-living people (PLIC study: n = 2,606;
average age 66 years). The selected cohort was representative
of the entire PLIC cohort in terms of age, gender, and clinical pa-
rameters according to the Kolmogorov-Smirnov test; individuals
were stratified in three groups (i.e. lean, overweight, and obese),
based onBMI, and a number of biochemical and cellular markers
of their peripheral blood were analyzed (Table S1). In particular,
this analysis revealed increased total lymphocyte counts in the
blood of overweight and obese as compared to lean individualsFigure 2. HFD-Induced Metabolic Stress Promotes the Differentiation
Phenotype in Mice
(A–F) Cell surface staining of CCR7 (A), CD62L (B), CXCR3 (C), LFA1 (D), CD25 (E)
of the HFD or CD Marilyn female donor mice used in Figures 1A–1D (absolute nu
(G) Ex vivo chemotaxis (3 hr, 6 hr, and 24 hr time points) of in vivo-primed CD4+ T
mice used in Figures 1A–1D in response to CXCL10 (300 ng/mL), CCL19/21 (200
(H and I) Intracellular staining of IFNg (H) and IL4 (I) in in vivo-primed CD4+ T cel
(A–F) n = 3–6 independent donors.
(G) n = 3 independent donors (each donor was tested in duplicate).
(H and I) n = 5 independent mice. The values denote mean ± SEM. *p < 0.05; **p(Figure 3A; Table S1). From this cohort, a detailed immunophe-
notype was performed in a group of n = 187 subjects. Again,
these individuals were selected by probability sampling and
were representative of the entire cohort according to the Kolmo-
gorov-Smirnov test. Specific subsets of circulating CD4+ T cells
were assessed by 10-parameter/8-color polychromatic flow
cytometry with CD3, CD4, CD45RO, CD45RA, CCR7, CCR5,
CXCR3, and HLA-DR as markers. The main CD4+ T cell subsets
present in the blood were identified by flow cytometry based on
a well-defined gating strategy (Figures S3A and S3B). The per-
centage of total T-helper lymphocytes was equal in the three
groups (Figure 3B); however, we found a strong association of
the obese condition with reduced naive T cells and increased
effector memory T cells (Figures 3C and 3D).
To gain further insights into the relationship in humansbetween
obesity and the effector memory phenotype of CD4+ T cells,
we focused on the few very obese patients in our cohort (BMI >
35 kg/m2, n = 5) and observed that the percentage of effector
memory T cells was raised to 18.2% (11.2–21.3) as compared
to 13.4% (8.8–18.25) of the entire obese population (Figures 3D
and 3E) and to 10.2% (8.4–12.5) of the lean population (see Fig-
ure 3D). To address the potential link of this phenotype with
obesity-related chronic inflammation,wealso analyzed theblood
levels of C reactive protein (CRP) in the lean, overweight, and
obese subjects. As expected, CRP levels rose progressively
with increasing BMI (Figure S4A), corroborating the correlation
between obesity and inflammation. However, no significant cor-
relation was observed between CRP levels and effector memory
T cells (Figure S4B). Furthermore, no correlation between
fasting glucose levels and effector memory T cells was observed
(p = 0.117). Also, effector memory T cells were not significantly
increased in type 2 diabetes subjects (n = 13) as compared to
the rest of the subjects in the cohort (p = 0.069).
The body mass fat distribution of each individual was also
analyzed by dual-energy X-ray absorptiometry (Figure S4C),
and the resulting android/gynoid ratio was correlated with the
percent of various T cell subsets. The android/gynoid ratio corre-
lated negatively with the naive T cell subset (Figure 3F) and posi-
tively with the CXCR3+ effector memory T cell subset (Figures 3G
and 3H). No significant correlation between the android/gynoid
ratio and HLADR+ or CCR5+ effector memory T cell subsets
was observed instead (Figures S4D and S4E).
Antigen Presentation by DC from Metabolically
Stressed Donors Does Not Affect T Cell Differentiation
to a Pro-inflammatory Effector Memory-like Phenotype
Prompted by previous suggestions that altered antigen presen-
tation by DC might affect T cell activation during metabolicof Primed CD4+ T Cells to a CXCR3+-LFA1+ Effector Memory-like
, and CD44 (F) in in vivo-primed CD4+ T cells isolated from pooled lymph nodes
mbers).
cells isolated from pooled lymph nodes of the HFD or CD Marilyn female donor
ng/mL of each chemokine), or media only.
ls isolated from mesenteric lymph nodes of HFD or CD mice.
< 0.01; and ***p < 0.001.
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Figure 3. Obesity and Body Fat Distribution
in Humans Positively Associates with an In-
crease in CXCR3+ Effector Memory T Cells
(A–D) Number of total lymphocytes (A) and % of
helper, naı¨ve, and effector memory T cells (B–D)
purified from the peripheral blood of lean, over-
weight, and obese subjects stratified according
to BMI.
(E) % of effector memory T cells purified from the
peripheral blood of obese subjects stratified ac-
cording to BMI either <35 orR35.
(F–H) Correlation of naı¨ve (F), effector memory (G),
and CXCR3+ (H) T cells with android/gynoid ratio.
(A) n = 1,172.
(B–D and F–H) n = 187.
(E) n = 21 BMI < 35, n = 5 BMI R 35. ANCOVA,
*p < 0.05.stress (Chen et al., 2014; Shamshiev et al., 2007), we assessed
the effect of splenic DC purified from HFD or CD animals on
T cell activation and differentiation. We found that in vitro co-
cultures of DC isolated from the spleen of CD-fed C57BL/6
male mice with CD4+ T cells obtained from the lymph nodes
of CD-fed Marilyn mice induced a strong proliferative response
of Marilyn CD4+ T cells, which was reduced when CD4+ T cells
were isolated from donors fed HFD (Figures 4A and S5A). In
contrast, DC purified from the spleen of C57BL/6 male mice
fed HFD were significantly less effective in promoting CD4+598 Cell Metabolism 25, 593–609, March 7, 2017T cell proliferation compared to their
‘‘CD-fed’’ counterpart, irrespective of
the T cell metabolic status (i.e., CD or
HFD CD4+ T cell donors [Figures 4A
and S5A], in line with previous reports;
Shamshiev et al., 2007). These data sug-
gest that the metabolic status of DC
plays a role in determining their ability
to promote CD4+ T cell proliferation.
However, it did not affect the differ-
entiation of CD4+ T cells to central versus
effector memory phenotype. Indeed,
HFD CD4+ T cells showed a higher
percent of CD44hi-CCR7lo-CD62lo-
CXCR3+ cells as compared to CD CD4+
T cells (consistent with Figures 2A–2C),
independent of whether they were co-
cultured with DC from HFD- or CD-fed
donors (Figure 4B). Similar results were
obtained in vivo when CD4+ T cells iso-
lated from female Marilyn mice were
co-injected with DC from HFD or CD
C57BL/6 male donors in C57BL/6 female
recipients (i.e., reduced CD4+ T cell pro-
liferation in the presence of DC from
HFD-fed mice and no effect on central
memory versus effector memory differ-
entiation; Figures S5B and S5C).
In line with previous reports (Sham-
shiev et al., 2007), DC isolated from
HFD-fed mice showed impaired activa-tion as indicated by reduced expression of the activation
markers CD80 and CD86 as compared to lean DC (Figure 4C).
CD4+ T Cell Exposure to Saturated FACauses Enhanced
Activation of a PI3K p110d-Akt-Dependent Pathway
upon Priming
Having ruled out a possible role for altered antigen presentation
by DC in biasing CD4+ T cell differentiation to the CXCR3+
effector memory phenotype observed during HFD-induced
metabolic stress, we sought to establish whether CD4+ T cell
(legend on next page)
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intrinsic alterations were responsible for this event by interro-
gating pathways controlling nutrient responses in T cells. PI3K/
Akt and mammalian target of rapamycin complexes (mTORC1
and mTORC2) are known to be rapidly activated upon T cell
priming and control transcriptional and metabolic programs
that sustain cell activation (Finlay et al., 2012; Macintyre et al.,
2011). We found a substantial increase in the levels of Akt activa-
tion (phosphorylation at serine 473, a target of mTORC2) in
in vivo-primed CD4+ T cells isolated from the lymph nodes of
HFD- as compared to CD-fed mice (Figure 5A, compare lanes
6–8 versus 1–2). Similar results were obtained with CD4+
T cells isolated from the peripheral blood of obese versus lean
individuals selected from the PLIC cohort (Figure 5B). In
contrast, threonine 308 on Akt and the mTORC1 target S6 did
not undergo any significant modulation when comparing in vivo-
primed CD4+ T cells isolated from the lymph nodes of HFD
or CD mice (Figures 5A and S6A). In line with recent literature
(Finlay et al., 2012; Macintyre et al., 2011), our data suggest
that CD4+ T cell priming following HFD regimen triggers a
PI3K/Akt pathway via mTORC2, but does not result in down-
stream mTORC1 activation.
A recent report has implicated direct signaling induced by
dietary FA in T cell differentiation in the gut, with middle- and
long-chain FA supporting Th1 and Th17 cell differentiation and
short-chain FA promoting Treg cell development (Haghikia
et al., 2015). In line with previous evidence, using lipidomic anal-
ysis, we found that HFD alters the fatty acid and phospholipid
profile of T cells (Figure S6B), resulting in increased membrane
fluidity (Figure 5C). This might underlay a reduced threshold for
TCR clustering and activation in HFD (Swamy et al., 2016).
Indeed, ImageStream analysis enabled us to observe that
in vitro activation of T cells isolated from HFD as compared to
CD mice results in increased aggregation of Cholera enterotoxin
(CTx) B staining (Figures 5D and S6C), indicative of enhanced
formation of lipid rafts, a key signaling event downstream of
TCR engagement (Viola et al., 1999). The saturated FA palmitate
has been shown to directly promote the activation of the inflam-
masome via NLRP3 and ASC (Wen et al., 2011) and of the Toll-
like receptor (TLR) 4/MyD88 pathway (Eguchi et al., 2012). We
therefore reasoned that the observed effector memory pheno-
type and enhanced activation of the PI3K/Akt pathway during
CD4+ T cell ‘‘HFD priming’’ could be due to a direct effect of
the saturated FA palmitate, whose levels increase during HFD.
Mirroring the results shown in Figures 2A–2D, we found that
palmitate enriched diet (PED)-fed animals displayed an increase
in the size of the CD44hi- CCR7lo-CD62Llo-CXCR3+-LFA1+
effector memory-like CD4+ T cell population and no difference
in the CD44hi-CCR7hi-CD62Lhi central memory CD4+ T cells as
compared to CD4+ T cells primed in the corresponding palmitateFigure 4. Antigen Presentation by DC from Metabolically Stressed D
Effector Memory-like Phenotype
(A) Dot plots and quantification of in vitro proliferation of CFSE-labeled CD4+ T
incubated for 3 days with CD11c+ DC isolated from the spleen of HFD or CD C57B
dilution of the CFSE-label.
(B) Cell surface staining of CD44, CCR7, CD62L, and CXCR3 in the undivided po
(C) Cell surface staining of CD40, CD80, and CD86 in CD11c+ DC used in (A).
(A and B) n = 3 independent mice (each mouse was tested in triplicate).
(C) n = 3 independent mice. The values denote mean ± SEM. **p < 0.01 and ***p
600 Cell Metabolism 25, 593–609, March 7, 2017control diet (PCD) fed-mice (Figures 5E–5H). In contrast, the size
of the naive T cell subset was reduced upon PED (Figures 5E–
5H). Further, CD4+ T cells were cultured overnight with IL-7 in
the presence or absence of either palmitic or linoleic acid at a
concentration which mirrors plasma levels in obese individuals
(200 mM), followed by activation with anti-CD3 and anti-CD28
for the indicated time points. As shown in Figure 5I, CD4+
T cell activation in the presence of palmitic acid for 2 hr showed
a trend of enhanced Akt activation compared to linoleic acid or
untreated control without any modulation of S6. In similar exper-
imental settings, only CD4+ T cell activation in the presence of
palmitic, but not stearic, acid for 48 hr led to reduced levels of
CCR7 and CD62LmRNA (Figure 5J). In line with previous reports
(Eguchi et al., 2012; Wen et al., 2011), these data suggest the
existence of specific sensing mechanisms for palmitate.
To further link the activation of the PI3K/Akt pathway to the
observed specific CD4+ T cell differentiation during HFD priming,
we activated CD4+ T cells via CD3/CD28 antibody ligation in the
presence or absence of the Akt activator SC79. As expected,
such treatment led to marked Akt phosphorylation (Figure S6D).
Importantly, enhanced Akt activation led to reduced levels of
CCR7 and CD62L mRNA, as well as CCR7 protein (Figures 5K
and 5L), indicating that increased Akt activation during CD4+
T cell priming directly promotes the pathway leading to the
differentiation of effector memory-like T cells.
The PI3K, Akt Pathway Is Key for the Differentiation of
CXCR3+ Effector Memory T Cells
We addressed the question as to whether enhanced PI3K/Akt
activation as we observed during HFD priming in CD4+ T cells
was instrumental to the biased T cell differentiation to the
observed CXCR3+ effector memory phenotype. The p110d sub-
unit of PI3K is crucial for correct TCR signaling and T cell activa-
tion (Okkenhaug et al., 2002). Furthermore, p110d engagement
during T cell priming is instrumental for Akt activation and differ-
entiation toward an effector memory phenotype, at least in CD8+
T cells (Finlay et al., 2012; Macintyre et al., 2011). We therefore
took genetic and pharmacologic approaches to selectively
target p110d and Akt activities in vivo. First, allogeneic CD4+
T cells were primed in vivo in HFD-fed p110dD910A (expressing ki-
nase-dead p110d) or wild-type (WT) mice. Genetic inhibition of
p110d activity completely reversed CD4+ effector memory differ-
entiation in HFD-fed animals (Figures 6A–6D). This was accom-
panied by a reduction of both Akt activation on serine 473 (Fig-
ure 6E) and migration in response to the chemokine CXCL10
(Figure 6F). Similarly, administration of the selective p110d inhib-
itor IC87114 during priming prevented biased differentiation of
allogeneic CD4+ T cells toward an effector memory phenotype
upon priming (Figures 6G–6J). Of note, administration ofonors Does Not Affect T Cell Differentiation to a Pro-inflammatory
cells isolated from pooled lymph nodes of HFD or CD Marilyn female mice
L/6 male mice. The undivided and fourth division populations are quantified by
pulation of CFSE-labeled CD4+ T cells shown in (A).
< 0.001.
(legend on next page)
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IC87114 completely blocked Akt activation in HFD CD4+ T cells,
but only partially in CD mice (Figure 5A, lanes 9–11 versus 3–5).
Finally, to further causally link PI3K and Akt, we also treated CD
WT mice with the Akt-selective activator SC79. Similar to what
we had observed in vitro (Figures 5K and 5L), this treatment
led to increased effector memory differentiation to levels similar
to those observed in HFD-fed animals (Figures 6G–6J and S6E).
Inhibition of Fatty Acid Oxidation Prevents Enhanced
Effector Memory Differentiation in Saturated Fatty
Acid-Enriched Diet
Given the important role of FA oxidation (FAO) in the generation
of memory T cells (O’Sullivan et al., 2014), we assessed whether
this metabolic pathway contributes to enhanced effector mem-
ory differentiation upon priming following saturated fatty acid-
enriched diet (PED). As shown in Figures 5E–5H, enrichment of
dietary palmitate led to enhanced differentiation of primed
CD4+ T cells toward an effector memory phenotype. In vitro,
naive T cells increased their rate of oxidative phosphorylation
(OCR: oxygen consumption rate) only in response to palmitic,
but not stearic, acid (Figure 7A). Etomoxir is an irreversible inhib-
itor of carnitine palmitoyltransferase-1 (CPT-1), an upstream
enzyme in the FAO cascade. We injected mice i.p. with etomoxir
during priming in PED-fed mice and found that this treatment
completely prevented biased differentiation of effector memory
CD4+ T cells we observed upon priming following PED (Figures
7B–7E).
DISCUSSION
Chronic systemic inflammation in obesity is characterized by the
secretion of Th1 cytokines, as well as aberrant T cell infiltration of
non-lymphoid tissue, including adipose tissue and arterial wall.
Obese AT contains more Th1 lymphocytes and higher levels of
IFNg than its lean counterpart (Rocha et al., 2008). In this study,
we have tested the hypothesis that excess dietary saturated FA
directly affects the differentiation and trafficking of CD4+ T cells
to non-lymphoid tissues. We report that differentiation of mem-
ory CD4+ T cells primed in HFD-fed mice is biased toward aFigure 5. Direct Exposure of CD4+ T Cells to Saturated FA Causes E
Priming
(A) Levels and densitometric quantification of p-Akt (S473), Akt, p-S6 (S235/236
mesenteric lymph nodes of CD and HFD mice i.p. injected with the PI3K inhibito
(B) Levels and densitometric quantification of p-Akt (S473) and Akt protein expres
subjects.
(C) Membrane fluidity index in in vivo-primed CD4+ T cells isolated frommesenteri
to linoleic acid (C18:2).
(D) Cell surface staining of CTxB in in vitro activated (Act) CD4+ T cells isolated fro
CTxB is measured by bright detail intensity of the signal.
(E–H) Cell surface staining of CD44 with CCR7 (E), CD62L (F), CXCR3 (G), and LF
PED and PCD mice.
(I and J) Protein levels and densitometric quantification of p-Akt (S473), Akt, p-S6
CD62L (J) in CD4+ T cells isolated from pooled lymph nodes of mice and cultured
stearic acid (200 mM), followed by activation with plate bound anti-CD3 (0.5 mg/m
(K and L) Levels of CCR7 andCD62L gene expression (K) and CCR7 protein (L) in C
bound anti-CD3 (0.5 mg/mL) and anti-CD28 (2.5 mg/mL) for the indicated time po
(A and B) Each lane shows data from independent mouse/human samples.
(C–H) n = 3–6 independent mice.
(I) Representative data of n = 3 independent mice.
(J–L) 3–6 pooled mice. The values denote mean ± SEM. *p < 0.05; **p < 0.01; an
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phenotype without major changes in the size of the central
memory pool. These T cells display preferential trafficking to
non-lymphoid, inflammatory sites, as well as increased effector
function following adoptive transfer. Although metabolically
imbalanced DC from obese/dyslipidaemic hosts tend to support
Th1/Th17 responses (Chen et al., 2014; Eguchi et al., 2012;
Reynolds et al., 2012; Shamshiev et al., 2007), our data show
that they play no role in determining CD4+ T cell commitment
to effector memory-like phenotype nor homing. The CD4+
T cell developmental bias is insteadmediated by direct exposure
of T cells to saturated FA; i.e., palmitate, leading to enhanced
activation of a PI3K p110d-Akt-dependent pathway upon prim-
ing. Our data suggest that this pathway might involve mTORC2
leading to Akt activation, but does not result in the downstream
activation of mTORC1. The key role of the PI3K p110d/Akt axis
is further confirmed by our observation that selective inactivation
of p110d in HFD can reestablish homeostatic CD4+ T cell
responses.
A similar signaling cascade has previously been shown to
direct the differentiation of CD8+ effector T cells (Finlay et al.,
2012; Macintyre et al., 2011), whereby high levels of Akt activa-
tion led to the downregulation of CD62L and CCR7 expression
and redirected the trafficking of effector CD8+ T cells away
from the secondary lymphoid tissues into the sites of inflamma-
tion. Specifically, it has been shown that downstream of TCR
engagement, Akt controls transcriptional programs directing
cytotoxic T cell fate, but is dispensable for T cell metabolism
(Macintyre et al., 2011), while PDK1 directly regulates mTOR
and hypoxia-inducible factor 1, leading to an integrated control
of metabolism and migration of CD8+ T cells (Finlay et al.,
2012). In addition to showing that similar signaling events under-
lay the differentiation of CD4+ T cells, our data expand the reach
of these studies from the basic mechanisms of T cell activation
and effector functions control to the biased establishment of un-
wanted T cell responses; i.e., specific pro-inflammatory effector
and migratory phenotypes, in a pathophysiologic context such
as obesity. This is in line with a recent study showing the link be-
tween obesity and metabolic diseases via increased Th17 T cellnhanced Activation of a PI3K p110d-Akt-Dependent Pathway upon
), and b-actin protein expression in in vivo-primed CD4+ T cells isolated from
r IC87114 or left untreated.
sion in CD4+ T cells purified from the peripheral blood of lean and obese human
c lymph nodes of CD and HFDmice, calculated as the ratio of oleic acid (C18:1)
m the lymph nodes of CD and HFD mice. The quantification of aggregation of
A1 (H) in in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of
(S235/236), and S6 protein expression (I), and gene expression of CCR7 and
overnight with IL-7 (1 ng/mL) in the presence or absence of palmitic, linoleic, or
L) and anti-CD28 (2.5 mg/mL) for the indicated time points.
D4+ T cells isolated from pooled lymph nodes of mice, then activatedwith plate
ints in the presence or absence of the Akt activator SC79 (500 nM).
d ***p < 0.001.
(legend on next page)
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differentiation (Endo et al., 2015). It has also been reported that
obesity could cause impairment in the T cell memory response
to secondary influenza infection, thereby affecting vaccine effi-
cacy (Karlsson et al., 2010). As we did not observe major differ-
ences in the size of the central memory population upon priming
following HFD or CD, it is possible that central memory cells are
functionally impaired in obesity. In line with the above study, we
observed an altered DC function following HFD.
Interestingly, our data shown in Figure 5A suggest that in phys-
iologic conditions (CD), different upstream kinases might control
the activation of Akt induced upon T cell priming, as the p110d
inhibitor IC87114 did not completely block Akt phosphorylation.
By contrast, in HFD mice, Akt phosphorylation was completely
abrogated by IC87114, indicating that the enhancement of Akt
activation by dietary lipids is particularly dependent on p110d.
The molecular mechanisms of lipid exchange on the T cell mem-
brane in physiology and during HFD remain to be fully estab-
lished, as well as the question as to whether FA act by altering
the cell membrane lipid balance or by binding to specific recep-
tors, as recently suggested (Eguchi et al., 2012; Haghikia et al.,
2015; Wen et al., 2011). Our data showing increased membrane
fluidity, as well as enhanced formation of lipid rafts upon TCR
engagement, might provide some clues as to how excess dietary
saturated FA impact on T cell responses. Similarly, our data sug-
gest that specific mechanisms exist for palmitate sensing, which
remain to be defined. In this context, we have observed that
T cell exposure to FA at the time of TCR triggering in vitro is
not sufficient to induce the biased effector memory differentia-
tion we observed in vivo, suggesting that palmitate sensing
and alteration of the T cell membranemust occur prior to antigen
recognition. Hence, the need to maintain naive T cell viability
over prolonged culture with or without FA and in the absence
of antigen stimulation has been a major challenge in setting up
in vitro models to study T cell differentiation following prolonged
exposure to fat overload. We have partially overcome this issue
by adding IL-7 to the culture of naive T cells during incubation
with or without FA prior to TCR stimulation, and this led to the re-
sults we showed in Figures 5I and 5J. Defining in vitro systems of
immunization following prolonged exposure to certain nutrients
would be extremely useful to test pathways involved with T cell
differentiation, such as palmitate sensing.
The observation that etomoxir prevents biased differentiation
of effector memory CD4+ T cells upon priming following satu-
rated fatty acid-enriched diet supports the concept that prefer-
ential utilization of FAO during T cell activation promotes effector
memory CD4+ T cell differentiation following HFD. AMPK-
induced FAO has been shown to play an important role in the
generation of memory T cells (O’Sullivan et al., 2014). IncreasedFigure 6. The PI3K, Akt Pathway Is Key for the Differentiation of CXCR
(A–D) Cell surface staining of CD44 with CCR7 (A), CD62L (B), CXCR3 (C), and LF
HFD P110dD910A or WT C57BL/6 mice.
(E) Levels and densitometric quantification of p-Akt (S473), Akt, p-S6 (S235/236)
(F) Ex vivo chemotaxis (3 hr, 6 hr, and 24 hr time points) of in vivo-primed CD4+ T c
in response to CXCL10 (300 ng/mL), CCL19/21 (200 ng/mL of each chemokine),
(G–J) Cell surface staining of CD44 with CCR7 (G), CD62L (H), CXCR3 (I), and LFA
and HFD mice i.p. injected with the PI3K inhibitor IC87114, the Akt activator SC7
(A–E and G–J) n = 5 independent mice.
(F) n = 4 independent mice (each mouse was tested in duplicate). The values de
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2000). However, reduced AMPK activity is also observed in HFD
(Lindholm et al., 2013; Liu et al., 2006), and its reactivation by
metformin is known to ameliorate glucose tolerance in obesity/
type 2 diabetes. Thus, during HFD, AMPK-induced FAO is un-
likely to play a role in the biased effector memory CD4+ T cell dif-
ferentiation we observe. Whether and how an enhanced PI3K/
Akt pathway leads to enhanced FAO remain open questions.
The biased development of pro-inflammatory effector memory
CD4+ T cells occurred inmicewithin 4–8weeks from exposure to
HFD, a time that precedes overt obesity and associated compli-
cations. This might imply a causative role of altered T cell differ-
entiation in the pathology accompanying metabolic stress, and
that immune challenges occurring naturally in individuals before
the establishment of overt obesity could drive cardiovascular
disease later in life.
Finally, our observation that selective PI3K p110d and FAO in-
hibition can correct CD4+ biased differentiation might provide
targets for the therapeutic control of inflammation during meta-
bolic stress. Likewise, our study supports the notion that by
modulating metabolism, we can affect immune responses, a
relatively novel concept with substantial translational implica-
tions. In this regard, hints and hopes come from few recent
studies, such as the report that CD4+ T cells from systemic lupus
erythematosus (SLE) patients exhibited enhanced glycolysis and
mitochondrial metabolism that correlated with their activation
status and their excessive IFNg production was significantly
reduced upon in vitro treatment with metformin. The same study
also showed that in a number of murine lupus models the com-
bination of metformin and 2-deoxy-glucose led to normalization
of CD4+ T cell metabolism and overall reversed disease bio-
markers (Mehta and Chandel, 2015; Yin et al., 2015). Such
studies pave the way to further research efforts in similar
directions.
EXPERIMENTAL PROCEDURES
Ethical Statement
Human blood was obtained from healthy donors according to ethics approval
obtained from the Universita` degli Studi di Milano (Cholesterol and Health:
Education, Control and Knowledge - Studio CHECK [SEFAP/Pr.0003] - refer-
ence number Fa-04-Feb-01). All in vivo experiments were conducted under
the UK Home Office regulation (PPL 70/7443).
Study Population
The PLIC study (a substudy of theCHECK study) is a large survey of the general
population living in the northern area of Milan (n = 2,606; average age 66 years)
(Baragetti et al., 2013; Norata et al., 2006, 2007), followed at the Center for the
Study of Atherosclerosis, Bassini Hospital (Cinisello Balsamo, Milan, Italy). An
informed consentwas obtained from subjects in accordance to theDeclaration3+ Effector Memory T Cells
A1 (D) in in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of
, and S6 protein expression in in vivo-primed CD4+ T cells from (A)–(D).
ells isolated frommesenteric lymph nodes of HFD or CDOT-II P110dD910A mice
or media only.
1 (J) in in vivo-primed CD4+ T cells isolated frommesenteric lymph nodes of CD
9, or left untreated.
note mean ± SEM. *p < 0.05; **p < 0.01; and ***p < 0.001.
Figure 7. Inhibition of FAO Prevents Enhanced Effector Memory Differentiation in Saturated Fatty Acid-Enriched Diet
(A) OCR of naive CD4+ T cells isolated from pooled lymph nodes of mice and cultured overnight with IL-7 (1 ng/mL) in the presence or absence of palmitic or
stearic acid (200 mM).
(legend continued on next page)
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of Helsinki. For all participants, information on medical histories and therapies
was obtained, andBMI (Kg/m2) andwaist/hip ratio (W/H) were calculated. After
an overnight fast, blood samples were collected from the antecubital vein for
determination of lipid profile and glucose levels, as previously described (Am-
mirati et al., 2012;Baragetti et al., 2013; Norata et al., 2007). Information on total
leukocytes and subfraction counts was available for n = 1,172 subjects, repre-
sentatives of the entire population in terms of age, gender distribution, and clin-
ical parameters according to the Kolmogorov-Smirnov test. This cohort was
divided by BMI in accordance to the World Health Organization definition
(lean for BMI < 25 Kg/m2; overweight for 25 Kg/m2 % BMI < 30 Kg/m2; and
obese for BMIR 30 Kg/m2; http://www.who.int/en).
Polychromatic Flow Cytometry, Human Studies
Polychromatic flow cytometry (10-parameter/8-color) was performed (as pre-
viously described; Ammirati et al., 2012) to obtain a detailed characterization of
a total of n = 57 subsets of circulating CD4+ T cells from n = 187 subjects of the
PLIC study, representative of the entire population in terms of age, gender dis-
tribution, and clinical parameters according to the Kolmogorov-Smirnov test.
Whole blood from each subject was collected in EDTA anticoagulated tubes
(BD Vacutainer). Samples were stained and fixed on the day of collection.
We previously verified that there was no significant difference in the investi-
gatedmarker levels in samples stained immediately after collection in compar-
ison to samples stained up to a maximum 24 hr time interval post-sampling
and stored at room temperature. In order to reduce cellular loss and analysis
sampling bias in the specimen, the no wash, whole blood lyses technique
was used. Briefly, for each specimen, 50 mL of a mixture of eight antibodies
(CD3/CD4/CD45RO/CD45RA/CCR7/CCR5/CXCR3/HLA-DR) was added to
100 mL of whole blood, followed by 20 min incubation in the dark at room tem-
perature. In particular, the panel used consisted of the subsequent cellular sur-
face markers: CD3 (Pacific Blue-labeled, clone HIT3a, BD Pharmingen), CD4
(APC-Cy7, SK3, BD Biosciences), CCR5/CD195 (PE, 2D7, BD Pharmingen),
CXCR3/CD183 (FITC, 49801, R&D Systems), CCR7/CD197 (PE-Cy7, 3D12,
BD Pharmingen), HLA-DR (Quantum Red, HK14, Sigma-Aldrich), CD45RO
(APC, UCHL1, Caltag), and CD45RA (ECD, 2H4, IOTest, BeckmanCoulter). Af-
ter staining, the red blood cells were lysed and fixed with the Immune-Prep
System (Beckman Coulter). White cells, diluted in 1 mL total volume, were
analyzed on a LSR II Flow Cytometer (BD Biosciences) equipped with four la-
sers and standard optics. The antibodies were selected to minimize spectral
overlap. Furthermore, to reduce the non-specific fluorescence background
and optimize the fluorescence signal, we used appropriately titrated directly
conjugatedmonoclonal antibodies. To appropriately identify positively stained
cells and differentiate them from background autofluorescence for gate inclu-
sion, we used the FluorescenceMinusOne strategy. Fluorescence intensity for
each signal measured was standardized using multiple peak Rainbow Calibra-
tion Particles (Code RCP-30-5A, Spherotech) to allow reproducible and com-
parable median fluorescence intensity throughout the study period, as previ-
ously described (Ammirati et al., 2010). We identified seven principal T cell
subsets and 50 T cell subpopulations derived by principal subsets by means
of the combination of the surface markers. All data were acquired in FCS
format using FACSDiva software 5.0 (BD Biosciences). Lymphocytes were
identified and electronically gated on forward and orthogonal light scatter sig-
nals. The fluorescent signals for phenotype analyses were accumulated for
the gated lymphocytes. The raw data were stored electronically to a server
for archiving and data processing. Data were processed and analyzed using
FCS Express V3 Research edition (De Novo Software; http://www.
denovosoftware.com). Cell viability was >99%, as assessed using the Molec-
ular Probes Patented LIVE/DEAD Viability (Invitrogen), according to the manu-
facturer instructions.
T Cell Activation
In vitro: murine CD4+ T cells were isolatedwith commercially available isolation
kits (negative selection; EasySep, Invitrogen) according to manufacturer’s in-(B–E) Cell surface staining of CD44 with CCR7 (B), CD62L (C), CXCR3 (D), and LF
PED or PCD mice i.p. injected with etomoxir or left untreated.
(A) Six pooled mice tested in 6–10 replicates per treatment.
(B–E) n = 5 independent mice. The values denote mean ± SEM. *p < 0.05 and **
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superficial and deep cervical, lumbar, and sacral) of C57BL/6 mice and
activated with plate bound anti-CD3 (1 mg/mL, eBioscience), anti-CD28
(5 mg/mL, eBioscience), and IL-2 (10 ng/mL, Roche) in the presence or
absence of the Akt activator SC79 (500 nM, Tocris). In alternative, isolated
CD4+ T cells were cultured over night with IL-7 (1 ng/mL, PeproTech) in the
presence or absence of palmitic, linoleic, or stearic acid (200 mM, Sigma), fol-
lowed by activation with plate bound anti-CD3 (0.5 mg/mL, eBioscience) and
anti-CD28 (2.5 mg/mL, eBioscience).
In vivo: in Rag2KO Marilyn C57BL/6 female mice fed CD or HFD (test diet;
Table S2) for 8 weeks memory antigen-specific (HY-specific) CD4+ T cells
were generated by i.p. immunization with WT C57BL/6 male splenocytes
(1.5 3 106) for 14 days. T cells were then isolated from pooled lymph nodes
of these mice (Figures 1A–1D, 2A–2G, and S2A–S2F) and injected i.v. in recip-
ients (see Experimental Procedures, In Vivo Peritoneal Recruitment, below) or
used for chemotaxis or flow cytometry.
In p110dD910A or WT C57BL/6 mice fed HFD (or CD as control) or PED (or
PCD as control; test diet; Table S2) for 8 weeks, memory CD4+ T cells were
generated by intraperitoneal immunization with CBA/BALBc splenocytes
(1.5 3 106; allogeneic immunization) for 7 days. T cells were then isolated
frommesenteric lymph nodes of these mice and analyzed by FACS or western
blot (Figures 2H and 2I, 5A, 5E–5H, 6A–6E, 6G–6J, and 7). In this system,
the PI3K p110d inhibitor IC87114 (Tocris) was administered i.p. at a dose of
50 mg/kg daily during the 7-day immunization (Ying et al., 2012). The Akt acti-
vator SC79 (Tocris) was administered i.p. at a dose of 7 mg/kg daily during the
7-day immunization (Moreira et al., 2015). Etomoxir (Sigma) was administered
i.p. at a dose of 15 mg/kg daily during the 7-day immunization (Shriver and
Manchester, 2011).
In OT-II p110dD910A mice fed CD or HFD for 8 weeks, memory antigen-spe-
cific (OVA-specific) CD4+ T cells were generated by intraperitoneal immuniza-
tion with ovalbumin peptide (10 mg, Cambridge Research Biochemicals) and
Poly IC (1:1, Sigma) for 7 days. T cells were then isolated from mesenteric
lymph nodes of these mice (Figure 6F) and analyzed for chemotaxis.
In Vivo Peritoneal Recruitment
In vivo activated T cells from Rag2KO Marilyn female mice were isolated from
pooled lymph nodes of HFD- or CD-fed donors, labeled with CFSE (HFD;
3.3 mM, Invitrogen) or PKH26 (CD; 2 mM, Sigma), pooled together, and intrave-
nously injected in HFD or CD recipient male mice (5 3 106 cells/mouse) that
had received an intraperitoneal injection with zymosan (1 mg/mouse, Sigma)
and IFNg (600 U/mouse, PeproTech) 48 hr earlier. At 48 hr after injection,
blood, peritoneal lavage, peritoneal membrane, mesenteric lymph nodes,
and spleen were collected and analyzed by FACS for presence of CFSE-
and PKH26-labeled T cells.
Membrane and Intracellular FACS Staining, Murine Studies
Spleen and blood sampleswere lysed of their RBCs before staining. Dead cells
were excluded from analysis by staining with fixable Aqua Dead Cell Stain (In-
vitrogen). Isolated lymphocytes or DC were stained for surface markers: CD3,
CD4, CD8, CD25, CD44, CCR7, CD62L, CXCR3, LFA1, Vb6, CD40, CD80,
CD86, MHCII, CD11c, CD19, CD14, and F4/80 with fluorescently conjugated
primary antibodies (1:200, eBioscience/BioLegend) at 4C for 30 min (37C
for CCR7) in FACS buffer (PBS + 2% FCS + 0.1% sodium azide) and fixed
at 4C for 30 min with 1% PFA in FACS buffer. For intracellular staining,
isolated lymphocytes were incubated in permeabilization/fixation buffer
(eBioscience) at 4C for 1 hr. Samples were washed in permeabilization buffer
and stained for the cytokines/chemokine IFNg, IL4 (1:200, eBioscience/
BioLegend) and CXCL10 (1:200, Stratech) with fluorescently conjugated pri-
mary antibodies at 4C for 30 min in permeabilization buffer. All samples
were then assessed by flow cytometry using a LSRFortessa (BD Biosciences)
and FlowJo version 10 software. Dot plots were concatenated to be represen-
tative of the independent biological replicates used in each experiment.A1 (E) in in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of
p < 0.01.
Chemotaxis
Chemotaxis assays were performed in 5 mm transwell inlays (Corning). In vivo
primed lymphocytes were isolated from mice fed CD or HFD for 8 weeks, sus-
pended in migration medium (RPMI 2% FCS), and seeded in the upper trans-
well chamber (3 3 105 cells/transwell). Chemokines (PeproTech) were added
to the lower chamber, CXCL10 (300 ng/mL), or CCL19/21 (200 ng/mL of each
chemokine). Migrated T cells were counted with a haemocytometer 3, 6, and
24 hr after seeding, then the percent of migrated cells were calculated.
Western Blot
Protein lysates were prepared from: (1) mesenteric lymph nodes isolated from
in vivo primedmice fedCDorHFD for 8weeks, (2) CD4+ T lymphocytes isolated
bymagnetic beads (Mylteni) from lean subjects (medianBMI 22.43 Kg/m2,min-
imum 17.67 Kg/m2, and maximum 24.54 Kg/m2) and obese subjects (median
BMI 31.64 Kg/m2, minimum 30.48 Kg/m2, and maximum 41.79 Kg/m2), and
(3) CD4+ T lymphocytes isolated from pooled lymph nodes and activated as
described above for the indicated time points. Samples were lysed
in Nonidet P-40 lysis buffer (50 mMHEPES pH 8.0, 350 mMNaCl, 1% Nonidet
P-40, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 20 mM glycerol-2-phosphate,
1 mM PMSF, 1 mMDTT, 10 mg/mL aprotinin, 10 mg/mL leupeptin, and a prote-
ase inhibitor mixture; Roche). Equivalent amounts of protein as determined by
standard Bradford assay (Bio-Rad) were separated by SDS/PAGE and trans-
ferred to a Nylon membrane (GE Healthcare). Membranes were blocked for
2 hr at room temperature in 5% Milk/TBS-T (5% BSA/TBS-T for phosphoryla-
tion antibodies), incubated overnight at 4C with primary antibodies (1:1,000),
and subsequently with HRP-conjugated secondary antibody (Amersham
Bioscience) (1:5,000). Antibodies against p-Akt (S473 and T308), Akt, p-S6
(S235/236), S6 and b-actin were purchased from Cell Signaling. Antibody
against CCR7was purchased fromR&D. Density of bandswas calculated rela-
tive to Akt, S6, or b-actin as shown in figures via the use of ImageJ software.
RNA Isolation and Reverse Transcription
RNAwas isolated using commercially available kits (QIAGEN) according to the
manufacturer’s instructions and assessed for quality and quantity using ab-
sorption measurements. Reverse transcription to cDNA was performed ac-
cording to the manufacturer’s instruction (Applied Biosystems).
qRT-PCR
Gene expression analysis was done using SYBR Green Supermix (Bio-Rad) in
CFX connect light cycler (Bio-Rad), according to the manufacturer’s instruc-
tions. Gene-relative expression was calculated using the DDct method and
normalized to a reference control (GAPDH): F 50-GGCTCATGACCACAGT
CCA-30; R 50-CACATTGGGGGTAGGAACAC-30. CCR7 andCD62L primers se-
quences were the same as published in Finlay et al. (2012).
Mixed Leukocyte Reaction
In vitro: T cells were isolated from pooled lymph nodes of Rag2KO Marilyn
female mice fed CD or HFD for 8 weeks and were labeled with CFSE
(3.3 mM) in PBS for 10 min at room temperature. T cells (2 3 105/well) were
then stimulated with CD11c+ DC (7 3 104/well) isolated from the spleen of
C57BL/6 male mice fed CD or HFD for 8 weeks. CD11c+ DC were treated
with mitomycin C to prevent proliferation prior to incubation with T cells.
T cells were harvested 3 days later and CFSE dilution was assessed by flow
cytometry (Figures 4A, 4B, and S5A).
In vivo: T cells were isolated from pooled lymph nodes of Rag2KO Marilyn
female mice, labeled with CFSE (3.3 mM) in PBS for 10 min at room tempera-
ture, and intravenously injected in C57BL/6 recipient female mice (5 3 106
cells/mouse). Concurrently, CD11c+ DC were isolated from the spleen of
C57BL/6 male mice fed CD or HFD for 8 weeks and intraperitoneally injected
in the C57BL/6 recipient female mice (1/4 spleen derived DC/mouse). Cells
were harvested from the peritoneal lavage, spleen, and draining lymph nodes
5 days later and CFSE dilution was assessed by flow cytometry (Figures S5B
and S5C).
Skin Grafts
Rag2KO and Marilyn female mice fed CD or HFD for 8 weeks received a
C57BL/6 male-derived skin graft on the upper right back. Bandages were
removed 7 days post-transplantation. Some Rag2KO mice were i.v. injectedwith 13 106 CD4+ T cells isolated fromMarilyn females 9 days post-transplan-
tation. Mice were observed for rejection for a further 3 weeks. Mice were culled
4 weeks post-transplantation.
Lipid Raft Staining
T cells isolated from pooled lymph nodes of C57BL/6 mice fed CD or HFD
for 8 weeks were activated as described above for 4 hr or left inactivated. Cells
were stained with CTxB-FITC (8 mg/mL, Sigma) and CD4-PECy7 (1:200,
eBioscience) at 4C for 30 min in FACS buffer (PBS + 2%FCS + 0.1% sodium
azide) and fixed at 4C for 30 min with 1% PFA in FACS buffer. Samples were
assessed using ImageStream flow cytometer (Amnis) and IDEAS software. For
quantitative image analysis of lipid raft aggregation, bright field and fluorescent
cell images were acquired. Bright detail intensity of CTxB staining was used to
quantify lipid raft aggregation. The bright detail intensity feature calculates the
sum of intensity values from the brightest areas within a cell that are morpho-
logically defined as the peak fluorescence distributions of 3 pixel radius or less.
There were 5,000 CD4+ T cells that were analyzed per condition.
Seahorse Flux Analysis
Oxidative metabolism was measured with a Seahorse XF96 Extracellular Flux
Analyzer. As described before, isolated naive CD4+ T cells were cultured over
night with IL-7 in the presence or absence of palmitic or stearic acid. 2 3 105
CD4+ T cells were then seeded in a 96-well microplate in XF Assay Modified
DMEM and incubated in a non-CO2 incubator for 1 hr prior to the assay.
OCR was then measured according to the manufacturer’s instructions (Sea-
horse Bioscience).
Statistical Analysis
Statistical analysis of human data was performed using the SPSS v.21.0 for
Windows (IBM Corporation) program. A Kolmogorov-Smirnov test was per-
formed to test whether the studied cohort was representative of the entire
PLIC population in terms of age, gender distribution, and clinical parameters.
A Shapiro-Wilk test was performed to verify the normal distribution of linear
variables; median and inter-quartile range (IQR) was reported andMann-Whit-
ney U non-parametric test was performed. Outliers detection (above and
below 1.53 IQR) was performed by use of Grubb’s test. Spearman correlation
coefficients (r) were reported for univariate correlations between linear vari-
ables. ANOVA test was performed to compare clinical parameters and leuko-
cyte subfraction among subjects divided by BMI and then adjusted for age,
gender, and therapies by using analysis of covariances (ANCOVA). For all anal-
ysis, statistically relevant differences were considered for p values < 0.05.
For murine studies, data are expressed as mean ± SEM. Two-tailed
Student’s t test was used to compare two groups with parametric data distri-
bution. For multiple comparison analysis, 1-, 2-, or 3-way ANOVA was used,
unless otherwise specified (Figure 1E). In all cases, a p value of less than
5% was considered to be significant.
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